The first experimental evidence leading to the hypothesis linking α-synuclein and tau in a common pathological molecular mechanism was the observation of phosphorylated tau and α-synuclein in neurofibrillary tangles and Lewy bodies in patients with PD and DLB [191,192]. The gene discussed is MAPT; the disease is Lewy body dementia.